Insulin makers object to FDA plan for speeding arrival of biosimilar insulins

Insulin makers object to FDA plan for speeding arrival of biosimilar insulins

What to read around the web today

• Opinion: Why autism research needs more input from autistic people. Spectrum
• Insulin makers object to FDA proposal for speeding arrival of biosimilar insulins. STAT Plus
• Scientists offered €1,000 to publish null results. Times Higher Education
• Coronavirus test kits sent to states are flawed, CDC says. The New York Times
• How hospitals changed how they deal with stillbirth. The Atlantic